Cargando…

Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma

Glioblastoma are known for its aggressive intracranial course of disease, where the overall survival is less than 18 months. Of late, the World Health Organization has reclassified and renamed secondary glioblastomas as isocitrate dehydrogenase (IDH)-mutant grade 4 astrocytomas, which is relatively...

Descripción completa

Detalles Bibliográficos
Autores principales: Thimma Sudarsan, Rishan, Ramanujan, Vishnu, Rajendran, Adhithyan, Shafi, Sadiya, Patil, Sushma, Ghosh, Siddhartha, Jalali, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635773/
https://www.ncbi.nlm.nih.gov/pubmed/37969678
http://dx.doi.org/10.1055/s-0042-1757425
_version_ 1785146360758009856
author Thimma Sudarsan, Rishan
Ramanujan, Vishnu
Rajendran, Adhithyan
Shafi, Sadiya
Patil, Sushma
Ghosh, Siddhartha
Jalali, Rakesh
author_facet Thimma Sudarsan, Rishan
Ramanujan, Vishnu
Rajendran, Adhithyan
Shafi, Sadiya
Patil, Sushma
Ghosh, Siddhartha
Jalali, Rakesh
author_sort Thimma Sudarsan, Rishan
collection PubMed
description Glioblastoma are known for its aggressive intracranial course of disease, where the overall survival is less than 18 months. Of late, the World Health Organization has reclassified and renamed secondary glioblastomas as isocitrate dehydrogenase (IDH)-mutant grade 4 astrocytomas, which is relatively better than its IDH wild-type counterpart; however, overall survival remains poor. In such tumors, metastases outside the craniospinal neuraxis is very rare, and does sometimes present with symptoms which create a diagnostic dilemma and arriving at such diagnosis is still challenging even for the best of the clinicians worldwide. Here we present such a rare case scenario, where a grade 4 astrocytoma that has transformed from a low-grade glioma, presenting with bone metastases, its workup, treatment, and various possible mechanisms underlying such a rare event, and the need of such clinical scenario especially long-term survivors to be wary of distant metastases.
format Online
Article
Text
id pubmed-10635773
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-106357732023-11-15 Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma Thimma Sudarsan, Rishan Ramanujan, Vishnu Rajendran, Adhithyan Shafi, Sadiya Patil, Sushma Ghosh, Siddhartha Jalali, Rakesh South Asian J Cancer Glioblastoma are known for its aggressive intracranial course of disease, where the overall survival is less than 18 months. Of late, the World Health Organization has reclassified and renamed secondary glioblastomas as isocitrate dehydrogenase (IDH)-mutant grade 4 astrocytomas, which is relatively better than its IDH wild-type counterpart; however, overall survival remains poor. In such tumors, metastases outside the craniospinal neuraxis is very rare, and does sometimes present with symptoms which create a diagnostic dilemma and arriving at such diagnosis is still challenging even for the best of the clinicians worldwide. Here we present such a rare case scenario, where a grade 4 astrocytoma that has transformed from a low-grade glioma, presenting with bone metastases, its workup, treatment, and various possible mechanisms underlying such a rare event, and the need of such clinical scenario especially long-term survivors to be wary of distant metastases. Thieme Medical and Scientific Publishers Pvt. Ltd. 2022-12-31 /pmc/articles/PMC10635773/ /pubmed/37969678 http://dx.doi.org/10.1055/s-0042-1757425 Text en MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Thimma Sudarsan, Rishan
Ramanujan, Vishnu
Rajendran, Adhithyan
Shafi, Sadiya
Patil, Sushma
Ghosh, Siddhartha
Jalali, Rakesh
Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma
title Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma
title_full Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma
title_fullStr Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma
title_full_unstemmed Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma
title_short Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma
title_sort rare case of extracranial metastases in a patient with idh-mutant glioblastoma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635773/
https://www.ncbi.nlm.nih.gov/pubmed/37969678
http://dx.doi.org/10.1055/s-0042-1757425
work_keys_str_mv AT thimmasudarsanrishan rarecaseofextracranialmetastasesinapatientwithidhmutantglioblastoma
AT ramanujanvishnu rarecaseofextracranialmetastasesinapatientwithidhmutantglioblastoma
AT rajendranadhithyan rarecaseofextracranialmetastasesinapatientwithidhmutantglioblastoma
AT shafisadiya rarecaseofextracranialmetastasesinapatientwithidhmutantglioblastoma
AT patilsushma rarecaseofextracranialmetastasesinapatientwithidhmutantglioblastoma
AT ghoshsiddhartha rarecaseofextracranialmetastasesinapatientwithidhmutantglioblastoma
AT jalalirakesh rarecaseofextracranialmetastasesinapatientwithidhmutantglioblastoma